Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Colzi, A.
Zürcher, G.
Kettler, R.
Da Prada, M.
and
Schneider, E.
1992.
Neuro-Psychopharmaka.
p.
29.
McPherson, Mary Lynn
1992.
Management of Parkinson's disease.
Journal of Home Health Care Practice,
Vol. 4,
Issue. 4,
p.
31.
Galhardo, Ivanidton
Coutinho, Marcos Otávio de M.
Albuquerque, Eliedna S. de
and
Medeiros, Lilianny de O.
1993.
Parkinsonismo induzido pela flunarizina: a propósito de um caso.
Arquivos de Neuro-Psiquiatria,
Vol. 51,
Issue. 4,
p.
546.
Nizamie, S.Haque
and
Chatterjee, S.
1994.
Affective psychosis in Eales' disease and response to sodium valproate.
General Hospital Psychiatry,
Vol. 16,
Issue. 5,
p.
364.
Montastruc, JL
Llau, ME
Rascol, O.
and
Senard, JM
1994.
Drug‐induced parkinsonism: a review.
Fundamental & Clinical Pharmacology,
Vol. 8,
Issue. 4,
p.
293.
Kretschmer, B. D.
Winterscheid, B.
Danysz, W.
and
Schmidt, W. J.
1994.
Glycine site antagonists abolish dopamine D 2 but not D 1 receptor mediated catalepsy in rats.
Journal of Neural Transmission,
Vol. 95,
Issue. 2,
p.
123.
Schmidt, Werner J.
and
Kretschmer, Beate D.
1997.
Behavioural pharmacology of glutamate receptors in the basal ganglia.
Neuroscience & Biobehavioral Reviews,
Vol. 21,
Issue. 4,
p.
381.
Ziemann, Ulf
Tergau, Frithjof
Bruns, Dirk
Baudewig, Jürgen
and
Paulus, Walter
1997.
Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs.
Electroencephalography and Clinical Neurophysiology/Electromyography and Motor Control,
Vol. 105,
Issue. 6,
p.
430.
McNaught, Kevin St.P.
Carrupt, Pierre-Alain
Altomare, Cosimo
Cellamare, Saverio
Carotti, Angelo
Testa, Bernard
Jenner, Peter
and
Marsden, C.David
1998.
Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson’s disease.
Biochemical Pharmacology,
Vol. 56,
Issue. 8,
p.
921.
Chabolla, David R.
Maraganore, Demetrius M.
Ahlskog, J. Eric
O'Brien, Peter C.
and
Rocca, Walter A.
1998.
Drug-Induced Parkinsonism as a Risk Factor for Parkinson's Disease: A Historical Cohort Study in Olmsted County, Minnesota.
Mayo Clinic Proceedings,
Vol. 73,
Issue. 8,
p.
724.
Adler, Charles H.
1999.
DIFFERENTIAL DIAGNOSIS OF PARKINSON'S DISEASE.
Medical Clinics of North America,
Vol. 83,
Issue. 2,
p.
349.
Chalverus, Caroline A.
2001.
Clinically Important Meperidine Toxicities.
Journal of Pharmaceutical Care in Pain & Symptom Control,
Vol. 9,
Issue. 3,
p.
37.
Van Gerpen, J. A.
2002.
Drug-Induced Parkinsonism.
The Neurologist,
Vol. 8,
Issue. 6,
p.
363.
2004.
Drug-Induced Movement Disorders.
Vol. 20045530,
Issue. ,
2004.
Drug-Induced Movement Disorders.
Vol. 20045530,
Issue. ,
Morgan, John C
and
Sethi, Kapil D
2005.
Drug-induced tremors.
The Lancet Neurology,
Vol. 4,
Issue. 12,
p.
866.
Morgan, John
and
Sethi, Kapil
2005.
Handbook of Essential Tremor and Other Tremor Disorders.
Vol. 20054440,
Issue. ,
p.
329.
Mena, Maria A
and
de Yébenes, Justo G
2006.
Drug-induced parkinsonism.
Expert Opinion on Drug Safety,
Vol. 5,
Issue. 6,
p.
759.
Ubeda, J.V.
2007.
Comparative features of the epidemiology of multiple sclerosis and Parkinson's disease: Environmental factors of potential etiological importance.
Journal of the Neurological Sciences,
Vol. 262,
Issue. 1-2,
p.
54.
Gubitz, A.K.
Corriveau, R.A.
and
Gwinn, K.
2010.
Encyclopedia of Movement Disorders.
p.
413.